Sanjivani Paranteral Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 328426, "name": "Sanjiv.Parant.", "stock_name": "Sanjiv.Parant.", "full_name": "Sanjivani Paranteral Ltd", "name_url": "stocks-analysis/sanjivparant", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "150.00", "chg": 0.1, "chgp": "0.07%", "dir": 1, "prev_price": "149.90", "mcapval": "185.00 Cr", "mcap": "Micro Cap", "scripcode": 531569, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE860D01013", "curr_date": "Jun 23, 03:30 PM", "curr_time": "20:31 PM", "last_traded_at": "Jun 23, 03:30 PM IST", "bse_nse_vol": "14.52 k", "exc_status": "Active", "traded_date": "Jun 23, 2026", "traded_date_str": "2026 06 23", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sanjivparant-328426-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Sanjivani Paranteral Ltd Upgraded to Sell Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-upgraded-to-sell-amid-mixed-financial-and-technical-signals-4068042", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SanjivaniParant_mojoScore_4068042.png", "date": "2026-06-23 08:03:32", "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 22 June 2026. This change reflects a nuanced shift in the company’s technical outlook amid ongoing financial headwinds and valuation considerations. While the company’s recent quarterly results remain subdued, improvements in technical indicators and a fair valuation relative to peers have contributed to the revised stance." }, { "title": "Sanjivani Paranteral Ltd Downgraded to Strong Sell Amid Valuation and Financial Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-downgraded-to-strong-sell-amid-valuation-and-financial-concerns-4055046", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SanjivaniParant_mojoScore_4055046.png", "date": "2026-06-16 08:03:44", "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 15 June 2026. This shift reflects a reassessment across key parameters including valuation, financial trends, quality metrics, and technical indicators, signalling heightened caution for investors amid deteriorating fundamentals and market underperformance." }, { "title": "Sanjivani Paranteral Ltd’s Volatile Week: -0.41% Price Change Amid Valuation Upgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltds-volatile-week--041-price-change-amid-valuation-upgrade-4051576", "imagepath": "", "date": "2026-06-13 14:05:03", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>8 Jun:</strong> Stock opens at Rs.147.35, down 0.44% as Sensex falls 1.33%</p>\n <p><strong>9 Jun:</strong> Price rebounds to Rs.150.00 (+1.80%) alongside Sensex’s 0.88% gain</p>\n <p><strong>10 Jun:</strong> Sharp decline to Rs.140.00 (-6.67%) amid weak market sentiment</p>\n <p><strong>11 Jun:</strong> Rating upgraded to Sell by MarketsMOJO; stock stabilises at Rs.140.15 (+0.11%)</p>\n <p><strong>12 Jun:</strong> Strong recovery to Rs.147.40 (+5.17%) as Sensex surges 2.20%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">We..." }, { "title": "Sanjivani Paranteral Ltd Upgraded to Sell on Improved Valuation and Financial Metrics", "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-upgraded-to-sell-on-improved-valuation-and-financial-metrics-4045863", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SanjivaniParant_mojoScore_4045863.png", "date": "2026-06-11 08:03:02", "description": "Sanjivani Paranteral Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a significant improvement in valuation metrics despite ongoing financial challenges. The pharmaceutical micro-cap’s recent performance and fundamental parameters have been carefully analysed, revealing a complex picture of valuation attractiveness counterbalanced by deteriorating quarterly financial results and subdued market returns." }, { "title": "Sanjivani Paranteral Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-signal-renewed-price-attractiveness-4045683", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SanjivaniParant_valuationdot_4045683.png", "date": "2026-06-11 08:00:17", "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a fair to a very attractive rating. Despite recent share price declines, the company’s improved price-to-earnings and price-to-book ratios relative to peers and historical averages suggest a compelling entry point for discerning investors." }, { "title": "Sanjivani Paranteral Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-strong-sell-4030447", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SanjivaniParant_mojoScore_4030447.png", "date": "2026-06-02 10:10:51", "description": "Sanjivani Paranteral Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 21 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 02 June 2026, providing investors with the most up-to-date view of the company’s performance and outlook." }, { "title": "Sanjivani Paranteral Ltd Gains 6.60%: 4 Key Factors Driving the Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-gains-660-4-key-factors-driving-the-weeks-volatility-4009116", "imagepath": "", "date": "2026-05-24 10:00:50", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>18 May:</strong> Quality grade downgraded to average, Mojo Grade shifted to Sell</p>\n <p><strong>21 May:</strong> Stock hits 52-week low at Rs.126</p>\n <p><strong>22 May:</strong> Mojo Grade downgraded further to Strong Sell amid weakening fundamentals</p>\n <p><strong>22 May:</strong> Valuation grade shifts from very attractive to fair despite 11.41% intraday gain</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.133.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">We..." }, { "title": "Sanjivani Paranteral Ltd Downgraded to Strong Sell Amid Deteriorating Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-downgraded-to-strong-sell-amid-deteriorating-fundamentals-4004315", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SanjivaniParant_mojoScore_4004315.png", "date": "2026-05-22 08:01:51", "description": "Sanjivani Paranteral Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The downgrade reflects deteriorating fundamentals, a shift in valuation metrics, and weakening financial performance, signalling caution for investors in this micro-cap pharmaceutical player." }, { "title": "Sanjivani Paranteral Ltd Valuation Shifts Amidst Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-amidst-market-volatility-4004158", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SanjivaniParant_valuationdot_4004158.png", "date": "2026-05-22 08:00:16", "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a very attractive to a fair valuation grade. This change comes amid significant price fluctuations and a deteriorating market sentiment, reflected in its recent downgrade to a Strong Sell rating by MarketsMOJO. Investors are now reassessing the stock’s price attractiveness in comparison to its historical averages and peer group benchmarks." } ], "total": 239, "sid": "328426", "stock_news_url": "https://www.marketsmojo.com/news/sanjivani-paranteral-328426" }, "announcements": [ { "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011", "datetime": "11-Jun-2026", "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ashwani Khemka", "source": "BSE" }, { "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance", "datetime": "29-May-2026", "details": "Annual Secretarial Compliance Report for the financial year ended 31st March 2026", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 21St May 2026", "datetime": "21-May-2026", "details": "Dear Sir/Madam Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Thursday 21st May 2026 inter alia considered and approved the appointment of Mr. Bhavesh M. Rathod Chartered Accountants Registered Valuer for carrying out valuation and determination of issue price of the proposed warrants to be issued by way of preferential issue", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Sanjivani Paranteral Ltd has declared <strong>5%</strong> dividend, ex-date: 19 Sep 25", "dt": "2025-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

8 Jun: Stock opens at Rs.147.35, down 0.44% as Sensex falls 1.33%

9 Jun: Price rebounds to Rs.150.00 (+1.80%) alongside Sensex’s 0.88% gain

10 Jun: Sharp decline to Rs.140.00 (-6.67%) amid weak market sentiment

11 Jun: Rating upgraded to Sell by MarketsMOJO; stock stabilises at Rs.140.15 (+0.11%)

12 Jun: Strong recovery to Rs.147.40 (+5.17%) as Sensex surges 2.20%

We...

Read full news article

Sanjivani Paranteral Ltd Upgraded to Sell on Improved Valuation and Financial Metrics

2026-06-11 08:03:02

Sanjivani Paranteral Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a significant improvement in valuation metrics despite ongoing financial challenges. The pharmaceutical micro-cap’s recent performance and fundamental parameters have been carefully analysed, revealing a complex picture of valuation attractiveness counterbalanced by deteriorating quarterly financial results and subdued market returns.

Read full news article

Sanjivani Paranteral Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-06-11 08:00:17

Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a fair to a very attractive rating. Despite recent share price declines, the company’s improved price-to-earnings and price-to-book ratios relative to peers and historical averages suggest a compelling entry point for discerning investors.

Read full news article

Sanjivani Paranteral Ltd is Rated Strong Sell

2026-06-02 10:10:51

Sanjivani Paranteral Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 21 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 02 June 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read full news article

Sanjivani Paranteral Ltd Gains 6.60%: 4 Key Factors Driving the Week’s Volatility

2026-05-24 10:00:50

Key Events This Week

18 May: Quality grade downgraded to average, Mojo Grade shifted to Sell

21 May: Stock hits 52-week low at Rs.126

22 May: Mojo Grade downgraded further to Strong Sell amid weakening fundamentals

22 May: Valuation grade shifts from very attractive to fair despite 11.41% intraday gain

Week Open

Rs.133.75

We...

Read full news article

Sanjivani Paranteral Ltd Downgraded to Strong Sell Amid Deteriorating Fundamentals

2026-05-22 08:01:51

Sanjivani Paranteral Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The downgrade reflects deteriorating fundamentals, a shift in valuation metrics, and weakening financial performance, signalling caution for investors in this micro-cap pharmaceutical player.

Read full news article

Sanjivani Paranteral Ltd Valuation Shifts Amidst Market Volatility

2026-05-22 08:00:16

Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a very attractive to a fair valuation grade. This change comes amid significant price fluctuations and a deteriorating market sentiment, reflected in its recent downgrade to a Strong Sell rating by MarketsMOJO. Investors are now reassessing the stock’s price attractiveness in comparison to its historical averages and peer group benchmarks.

Read full news article

View All News